Iodide

Iodide

SCHEMBL14736217

Cn1cc(-c2ccc[n+](C)c2)nc1CCNC(=O)OC(C)(C)C.[I-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
GFER P55789 1/20 0.46
PDE10A Q9Y233 9/20 0.40
NQO2 P16083 1/20 0.39
CKS1B P61024 1/20 0.39
SKP1 P63208 1/20 0.39
SKP2 Q13309 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
TTK P33981 1/20 0.36
BCHE P06276 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14736561 0.85 PDE10A (0.51) ALDH1A1GFERPDE10ACKS1BSKP1
SCHEMBL14736640 0.82 PDE10A (0.54) ALDH1A1GFERPDE10A
SCHEMBL14736325 0.79 PDE10A (0.57) ALDH1A1GFERPDE10ANQO2KDM4E
SCHEMBL14736629 0.75 PDE10A (0.56) ALDH1A1GFERPDE10AADORA3ADORA1
SCHEMBL1929544 0.73 HDAC1 (0.44) PDE10ACKS1BSKP1SKP2KDM4E
SCHEMBL14736776 0.72 PDE10A (0.57) ALDH1A1GFERPDE10ACKS1BSKP1
SCHEMBL18764883 0.72 ALDH1A1 (0.51) ALDH1A1GFERNQO2CKS1BSKP1
SCHEMBL18764760 0.71 ALDH1A1 (0.50) ALDH1A1GFERNQO2NPSR1KDM4E
SCHEMBL17274166 0.69 PDE10A (0.56) PDE10A
Iodide SCHEMBL22366539 0.69 CYP2C19 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2753604-B1 PDE10 MODULATORS HOFFMANN LA ROCHE (CH) 2015-08-19 EP disclosed
US-8772510-B2 PDE10 modulators HOFFMANN-LA ROCHE INC. (US) 2014-07-08 US disclosed
EP-2574607-A1 PDE10 modulators F. Hoffmann-La Roche AG (CH) 2013-04-03 EP disclosed
WO-2013034506-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-14 WO disclosed
US-20130059833-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059833-A1 PDE10 MODULATORS PDE10A, PDE5A, PDE2A ALDH1A1 775/4885GFER 3613/4885PDE10A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.